_id
691482d6ccc777a4e85d93f7
Ticker
NNBP
Name
Nanobac Pharmaceuticals Incorporated
Exchange
OTCCE
Address
3000 Bayport Drive, Tampa, FL, United States, 33607
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
Description
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-05T11:31:41.136Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
124752
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2007-12-31
Revenue
4368
Cost Of Revenue
3690
Gross Profit
678
Operating Expenses
665775
Operating Income
-661407
Interest Expense
48715
Pretax Income
-1167068
Net Income
-1167068
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-15142.10164835165
Total Other Income Expense Net
-505661
Cash
3933
Short Term Investments
-
Receivables
1869
Inventories
10303
Total Current Assets
30761
Property Plant Equipment
37502
Total Assets
7219762
Payables
980369
Short Term Debt
4121957
Long Term Debt
-
Total Liabilities
9582022
Equity
-2362260
Bs_currency_symbol
USD
Depreciation
113814
Change In Working Capital
-
Cash From Operations
-110316
Capital Expenditures
1
Cash From Investing
-301
Cash From Financing
157578
Net Change In Cash
3272
Cf_currency_symbol
USD
PE
-
PB
-
ROE
49.40472259615792
ROA
-16.16490959120259
FCF
-110317
Fcf Percent
-25.25572344322344
Piotroski FScore
1
Health Score
41
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2007-12-31
Quarters > 0 > income Statement > revenue
4368
Quarters > 0 > income Statement > cost Of Revenue
3690
Quarters > 0 > income Statement > gross Profit
678
Quarters > 0 > income Statement > operating Expenses
665775
Quarters > 0 > income Statement > operating Income
-661407
Quarters > 0 > income Statement > interest Expense
48715
Quarters > 0 > income Statement > pretax Income
-1167068
Quarters > 0 > income Statement > net Income
-1167068
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-15142.10164835165
Quarters > 0 > income Statement > total Other Income Expense Net
-505661
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3933
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1869
Quarters > 0 > balance Sheet > inventories
10303
Quarters > 0 > balance Sheet > total Current Assets
30761
Quarters > 0 > balance Sheet > property Plant Equipment
37502
Quarters > 0 > balance Sheet > total Assets
7219762
Quarters > 0 > balance Sheet > payables
980369
Quarters > 0 > balance Sheet > short Term Debt
4121957
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9582022
Quarters > 0 > balance Sheet > equity
-2362260
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1167068
Quarters > 0 > cash Flow > depreciation
113814
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-110316
Quarters > 0 > cash Flow > capital Expenditures
1
Quarters > 0 > cash Flow > cash From Investing
-301
Quarters > 0 > cash Flow > cash From Financing
157578
Quarters > 0 > cash Flow > net Change In Cash
3272
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
49.40472259615792
Quarters > 0 > ratios > ROA
-16.16490959120259
Quarters > 0 > ratios > FCF
-110317
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-25.25572344322344
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2007-09-30
Quarters > 1 > income Statement > revenue
5809
Quarters > 1 > income Statement > cost Of Revenue
4667
Quarters > 1 > income Statement > gross Profit
1142
Quarters > 1 > income Statement > operating Expenses
541292
Quarters > 1 > income Statement > operating Income
-535483
Quarters > 1 > income Statement > interest Expense
48236
Quarters > 1 > income Statement > pretax Income
-835763
Quarters > 1 > income Statement > net Income
-835763
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-9218.161473575487
Quarters > 1 > income Statement > total Other Income Expense Net
-300280
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
661
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1811
Quarters > 1 > balance Sheet > inventories
9983
Quarters > 1 > balance Sheet > total Current Assets
40043
Quarters > 1 > balance Sheet > property Plant Equipment
41466
Quarters > 1 > balance Sheet > total Assets
7342051
Quarters > 1 > balance Sheet > payables
967976
Quarters > 1 > balance Sheet > short Term Debt
3915716
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9500340
Quarters > 1 > balance Sheet > equity
-2158289
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-835763
Quarters > 1 > cash Flow > depreciation
114556
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-200281
Quarters > 1 > cash Flow > capital Expenditures
1
Quarters > 1 > cash Flow > cash From Investing
-3221
Quarters > 1 > cash Flow > cash From Financing
241046
Quarters > 1 > cash Flow > net Change In Cash
-306
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
38.72340543828931
Quarters > 1 > ratios > ROA
-11.383236101192978
Quarters > 1 > ratios > FCF
-200282
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-34.47787915303839
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2007-06-30
Quarters > 2 > income Statement > revenue
2432
Quarters > 2 > income Statement > cost Of Revenue
1902
Quarters > 2 > income Statement > gross Profit
530
Quarters > 2 > income Statement > operating Expenses
681819
Quarters > 2 > income Statement > operating Income
-679387
Quarters > 2 > income Statement > interest Expense
43723
Quarters > 2 > income Statement > pretax Income
-716562
Quarters > 2 > income Statement > net Income
-716562
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-27935.320723684206
Quarters > 2 > income Statement > total Other Income Expense Net
-37175
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
967
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1695
Quarters > 2 > balance Sheet > inventories
67765
Quarters > 2 > balance Sheet > total Current Assets
133225
Quarters > 2 > balance Sheet > property Plant Equipment
45614
Quarters > 2 > balance Sheet > total Assets
7548290
Quarters > 2 > balance Sheet > payables
929520
Quarters > 2 > balance Sheet > short Term Debt
3628351
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8616090
Quarters > 2 > balance Sheet > equity
-1067800
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-716562
Quarters > 2 > cash Flow > depreciation
115286
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-285074
Quarters > 2 > cash Flow > capital Expenditures
1
Quarters > 2 > cash Flow > cash From Investing
-3221
Quarters > 2 > cash Flow > cash From Financing
274473
Quarters > 2 > cash Flow > net Change In Cash
-5264
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
67.10638696385091
Quarters > 2 > ratios > ROA
-9.49303749590967
Quarters > 2 > ratios > FCF
-285075
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-117.21833881578948
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2007-03-31
Quarters > 3 > income Statement > revenue
5012
Quarters > 3 > income Statement > cost Of Revenue
4260
Quarters > 3 > income Statement > gross Profit
752
Quarters > 3 > income Statement > operating Expenses
2562546
Quarters > 3 > income Statement > operating Income
-2557534
Quarters > 3 > income Statement > interest Expense
46230
Quarters > 3 > income Statement > pretax Income
-3856718
Quarters > 3 > income Statement > net Income
-3856718
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-51028.21229050279
Quarters > 3 > income Statement > total Other Income Expense Net
-1299184
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6231
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
164
Quarters > 3 > balance Sheet > inventories
67060
Quarters > 3 > balance Sheet > total Current Assets
98550
Quarters > 3 > balance Sheet > property Plant Equipment
51426
Quarters > 3 > balance Sheet > total Assets
7628300
Quarters > 3 > balance Sheet > payables
647661
Quarters > 3 > balance Sheet > short Term Debt
3310436
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7973350
Quarters > 3 > balance Sheet > equity
-345050
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3856718
Quarters > 3 > cash Flow > depreciation
116646
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-315215
Quarters > 3 > cash Flow > capital Expenditures
1532
Quarters > 3 > cash Flow > cash From Investing
52089
Quarters > 3 > cash Flow > cash From Financing
237789
Quarters > 3 > cash Flow > net Change In Cash
-33274
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
1117.727285900594
Quarters > 3 > ratios > ROA
-50.55802734554226
Quarters > 3 > ratios > FCF
-316747
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-63.197725458898645
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2007-12-31
Annuals > 0 > income Statement > revenue
17621
Annuals > 0 > income Statement > cost Of Revenue
14519
Annuals > 0 > income Statement > gross Profit
3102
Annuals > 0 > income Statement > operating Expenses
4451432
Annuals > 0 > income Statement > operating Income
-4433811
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-6576111
Annuals > 0 > income Statement > net Income
-6576111
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-25162.08501220135
Annuals > 0 > income Statement > total Other Income Expense Net
-2142300
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3933
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1869
Annuals > 0 > balance Sheet > inventories
10303
Annuals > 0 > balance Sheet > total Current Assets
30761
Annuals > 0 > balance Sheet > property Plant Equipment
37502
Annuals > 0 > balance Sheet > total Assets
7219762
Annuals > 0 > balance Sheet > payables
980369
Annuals > 0 > balance Sheet > short Term Debt
4121957
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9582022
Annuals > 0 > balance Sheet > equity
-2362260
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6576111
Annuals > 0 > cash Flow > depreciation
460302
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-910886
Annuals > 0 > cash Flow > capital Expenditures
1533
Annuals > 0 > cash Flow > cash From Investing
48567
Annuals > 0 > cash Flow > cash From Financing
910886
Annuals > 0 > cash Flow > net Change In Cash
-35572
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
278.38218485687435
Annuals > 0 > ratios > ROA
-91.08487232681631
Annuals > 0 > ratios > FCF
-912419
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-51.78020543669485
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2006-12-31
Annuals > 1 > income Statement > revenue
225086
Annuals > 1 > income Statement > cost Of Revenue
79805
Annuals > 1 > income Statement > gross Profit
145281
Annuals > 1 > income Statement > operating Expenses
4454620
Annuals > 1 > income Statement > operating Income
-4229534
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-4973353
Annuals > 1 > income Statement > net Income
-4973353
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-1879.0746647947894
Annuals > 1 > income Statement > total Other Income Expense Net
-743819
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
39505
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
708
Annuals > 1 > balance Sheet > inventories
66352
Annuals > 1 > balance Sheet > total Current Assets
126503
Annuals > 1 > balance Sheet > property Plant Equipment
60321
Annuals > 1 > balance Sheet > total Assets
7824721
Annuals > 1 > balance Sheet > payables
408665
Annuals > 1 > balance Sheet > short Term Debt
5367205
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
9136383
Annuals > 1 > balance Sheet > equity
-1311662
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4973353
Annuals > 1 > cash Flow > depreciation
541278
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-2584882
Annuals > 1 > cash Flow > capital Expenditures
12759
Annuals > 1 > cash Flow > cash From Investing
-15490
Annuals > 1 > cash Flow > cash From Financing
2688945
Annuals > 1 > cash Flow > net Change In Cash
30530
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
379.1642206605055
Annuals > 1 > ratios > ROA
-63.55949304773934
Annuals > 1 > ratios > FCF
-2597641
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-11.540660014394499
Annuals > 1 > health Score
40
Annuals > 2 > quarter
2005-12-31
Annuals > 2 > income Statement > revenue
656802
Annuals > 2 > income Statement > cost Of Revenue
229446
Annuals > 2 > income Statement > gross Profit
427356
Annuals > 2 > income Statement > operating Expenses
3494493
Annuals > 2 > income Statement > operating Income
-2837691
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-3687337
Annuals > 2 > income Statement > net Income
-3687337
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-432.0466441941407
Annuals > 2 > income Statement > total Other Income Expense Net
-849646
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
8975
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3283
Annuals > 2 > balance Sheet > inventories
117280
Annuals > 2 > balance Sheet > total Current Assets
173263
Annuals > 2 > balance Sheet > property Plant Equipment
106952
Annuals > 2 > balance Sheet > total Assets
8969724
Annuals > 2 > balance Sheet > payables
313932
Annuals > 2 > balance Sheet > short Term Debt
2485576
Annuals > 2 > balance Sheet > long Term Debt
2836538
Annuals > 2 > balance Sheet > total Liabilities
6505003
Annuals > 2 > balance Sheet > equity
2464721
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3687337
Annuals > 2 > cash Flow > depreciation
759935
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-2365310
Annuals > 2 > cash Flow > capital Expenditures
40632
Annuals > 2 > cash Flow > cash From Investing
-40632
Annuals > 2 > cash Flow > cash From Financing
2326110
Annuals > 2 > cash Flow > net Change In Cash
-8933
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-149.60464084981626
Annuals > 2 > ratios > ROA
-41.108700780536836
Annuals > 2 > ratios > FCF
-2405942
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.663116129366232
Annuals > 2 > health Score
21
Annuals > 3 > quarter
2004-12-31
Annuals > 3 > income Statement > revenue
358361
Annuals > 3 > income Statement > cost Of Revenue
100470
Annuals > 3 > income Statement > gross Profit
257891
Annuals > 3 > income Statement > operating Expenses
7958744
Annuals > 3 > income Statement > operating Income
-7600383
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-8461140
Annuals > 3 > income Statement > net Income
-8518408
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-2120.8733651262273
Annuals > 3 > income Statement > total Other Income Expense Net
-860757
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
17908
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3395
Annuals > 3 > balance Sheet > inventories
70571
Annuals > 3 > balance Sheet > total Current Assets
115523
Annuals > 3 > balance Sheet > property Plant Equipment
124995
Annuals > 3 > balance Sheet > total Assets
9684307
Annuals > 3 > balance Sheet > payables
645491
Annuals > 3 > balance Sheet > short Term Debt
256447
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3573463
Annuals > 3 > balance Sheet > equity
6110844
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8518408
Annuals > 3 > cash Flow > depreciation
717070
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-3395744
Annuals > 3 > cash Flow > capital Expenditures
36765
Annuals > 3 > cash Flow > cash From Investing
164834
Annuals > 3 > cash Flow > cash From Financing
3215970
Annuals > 3 > cash Flow > net Change In Cash
-31847
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-139.398223878731
Annuals > 3 > ratios > ROA
-87.960945476016
Annuals > 3 > ratios > FCF
-3432509
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-9.578355345587271
Annuals > 3 > health Score
31
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
49.40472259615792
Profitability > metrics > ROA
-3793.985891225903
Profitability > metrics > Net Margin
-267.18589743589746
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-13.577070717438161
Risk > final Score
-24
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.006028819013132442
Liquidity > metrics > Quick Ratio
0.004009543882535142
Liquidity > final Score
10
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-14
Prev Risks > 1
-32
Prev Risks > 2
-191
Prev Liquidities > 0
10
Prev Liquidities > 1
11
Prev Liquidities > 2
10
Updated At
2026-01-22T21:14:23.696Z
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2007-12-31)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Nanobac Pharmaceuticals Incorporated
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2007-12-31)
(Last Updated 2007-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2007-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2007-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.